120 related articles for article (PubMed ID: 36642942)
1. Pharmacokinetics and Comparative Bioavailability of Test or Reference Capecitabine and Discrepant Pharmacokinetics Among Various Tumors in Chinese Solid Cancer Patients.
Li X; Cui D; Xiong J; Dang Q; Wen Q; Yan M; Li H; Jiang X; Lin C; Xie X; Wang T; Xiang L; Wang Y; Zheng L
Clin Pharmacol Drug Dev; 2023 Mar; 12(3):324-332. PubMed ID: 36642942
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic and Safety Comparison of Two Capecitabine Tablets in Patients with Colorectal or Breast Cancer Under Fed Conditions: A Multicenter, Randomized, Open-Label, Three-Period, and Reference-Replicated Crossover Study.
Wang CJ; Li T; Lin PP; Tao Y; Jiang X; Li X; Wen Q; Cao Y
Adv Ther; 2021 Sep; 38(9):4798-4814. PubMed ID: 34347254
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic and bioequivalence study of two capecitabine tablets in Chinese patients with breast, colorectal or gastric cancer under fed condition: A multicentric, randomized, open-label, single-dose, two-period, two-way crossover clinical trial.
Ma H; Zhao N; Luo S; Zhang Y; Yuan Z; Sun H; Gao S; Zhan X; Zhang L
Eur J Pharm Sci; 2023 Mar; 182():106373. PubMed ID: 36623698
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of bioequivalence and safety analysis of capecitabine tablets and Xeloda® under postprandial dosing conditions in Chinese patients with solid tumor.
Li H; Shan R; Ding J; Zhang J; Liu B; Ge Q; Cheng D; Li L; Zhang C; Su H; Li X; Li H; Ye J; Li H; Li F; Zhou H; Huo Q; Su Y
Expert Opin Drug Metab Toxicol; 2023 Dec; 19(12):1015-1021. PubMed ID: 38059472
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and bioequivalence of Ezetimibe tablet versus Ezetrol®:an open-label, randomized, two-sequence crossover study in healthy Chinese subjects.
Sun F; Liu Y; Li T; Lin P; Jiang X; Li X; Wang C; Gao X; Ma Y; Fu Y; Cao Y
BMC Pharmacol Toxicol; 2023 Feb; 24(1):7. PubMed ID: 36737825
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic and bioequivalence study of two capecitabine tablets in Chinese patients with solid tumor cancer.
Zong G; Li J; Gong X; Liu Y; Guo X
Cancer Chemother Pharmacol; 2024 Mar; ():. PubMed ID: 38453720
[TBL] [Abstract][Full Text] [Related]
7. Bioequivalence of two tablet formulations of capecitabine and exploration of age, gender, body surface area, and creatinine clearance as factors influencing systemic exposure in cancer patients.
Cassidy J; Twelves C; Cameron D; Steward W; O'Byrne K; Jodrell D; Banken L; Goggin T; Jones D; Roos B; Bush E; Weidekamm E; Reigner B
Cancer Chemother Pharmacol; 1999; 44(6):453-60. PubMed ID: 10550565
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics, Bioequivalence and Safety Evaluation of Two Ticagrelor Tablets Under Fasting and Fed Conditions in Healthy Chinese Subjects.
Wang J; Zhang H; Wang R; Cai Y
Drug Des Devel Ther; 2021; 15():1181-1193. PubMed ID: 33758499
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and Bioequivalence Evaluation of Two Montelukast Sodium Chewable Tablets in Healthy Chinese Volunteers Under Fasted and Fed Conditions.
Li W; Wang Y; Pei Y; Xia Y
Drug Des Devel Ther; 2021; 15():1091-1099. PubMed ID: 33727797
[TBL] [Abstract][Full Text] [Related]
10. Bioequivalence Study of Amitriptyline Hydrochloride Tablets in Healthy Chinese Volunteers Under Fasting and Fed Conditions.
Zhai Y; Wu L; Zheng Y; Wu M; Huang Y; Huang Q; Shentu J; Zhao Q; Liu J
Drug Des Devel Ther; 2020; 14():3131-3142. PubMed ID: 32801649
[TBL] [Abstract][Full Text] [Related]
11. Bioequivalence Study of Palbociclib Capsules in Healthy Chinese Subjects Under Fasting and Fed Conditions.
Chu NN; Zhang L; Wang J; Gu X; Ding Y; Huang K; Que LL; He Q
Clin Drug Investig; 2022 Jan; 42(1):53-63. PubMed ID: 34837169
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and relative bioavailability of two allopurinol tablets in healthy Chinese volunteers
.
Hou ZY; Cai HL; Deng Y; Li ZH; Cao SS; Chen Y; Li Y; Yan M; Zhang BK
Int J Clin Pharmacol Ther; 2017 Jun; 55(6):540-546. PubMed ID: 28438257
[TBL] [Abstract][Full Text] [Related]
13. Comparison of scaled-average, population, and individual bioequivalence on 2 tablets of pitavastatin calcium: a 3-period, reference-replicated, crossover study in healthy Chinese volunteers.
Huang YH; Li ZQ; Pan GX; Li YF; Liu Y; Sun JX; Gu XF; Li N; Wang BH
Clin Ther; 2014 Sep; 36(9):1205-1216.e6. PubMed ID: 25234550
[TBL] [Abstract][Full Text] [Related]
14. Comparative fasting bioavailability of 2 bepotastine formulations in healthy male Chinese volunteers: an open-label, randomized, single-dose, 2-way crossover study.
Shentu J; Zhou H; Hu X; Wu G; Wu L; Zhu M; Zhai Y; Zheng Y; Liu J
Clin Ther; 2014 Apr; 36(4):579-85. PubMed ID: 24656153
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and bioequivalence study of irbesartan tablets after a single oral dose of 300 mg in healthy Thai volunteers.
Wittayalertpanya S; Chariyavilaskul P; Prompila N; Sayankuldilok N; Eiamart W
Int J Clin Pharmacol Ther; 2014 May; 52(5):431-6. PubMed ID: 24725445
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and bioequivalence of two oral formulations of canagliflozin after single-dose administration in healthy Chinese subjects
.
Hu W; Yang Y; Zhang Q; Yang Y; Zhou R; Lu C; Liu Z
Int J Clin Pharmacol Ther; 2020 Jan; 58(1):57-65. PubMed ID: 31347489
[TBL] [Abstract][Full Text] [Related]
17. Bioequivalence and Pharmacokinetic Evaluation of Two Metformin Hydrochloride Tablets Under Fasting and Fed Conditions in Healthy Chinese Volunteers.
Huang XM; Wang GZ; He BB; Gao T; Long P; Zhang BK
Clin Pharmacol Drug Dev; 2020 Nov; 9(8):910-917. PubMed ID: 32936533
[TBL] [Abstract][Full Text] [Related]
18. A randomized, crossover study to determine bioequivalence of two brands of dexibuprofen 400 mg tablets in healthy Asian adult male subjects of Indian origin.
Menon S; Kadam N; Patil G; Mhatre P
Int J Clin Pharmacol Ther; 2008 Jan; 46(1):48-54. PubMed ID: 18218298
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics, safety, and bioequivalence of apixaban tablets in healthy Chinese subjects under fasting and fed conditions.
Luo HY; Yao ZJ; Long HZ; Zhou ZW; Xu SG; Li FJ; Cheng Y; Wen DD; Deng P; Guan YQ; Gao LC
Int J Clin Pharmacol Ther; 2023 Mar; 61(3):129-138. PubMed ID: 36458443
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic and bioequivalence study of new S-1 capsule in Chinese cancer patients.
Chen Y; Jiang Y; Qu J; Wang Q; Bai Y; Shi J; Shi Y; Chen X; Yang N; Heng J; Li K
Eur J Pharm Sci; 2020 Aug; 151():105384. PubMed ID: 32470574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
